SCHEMBL5999747

SCHEMBL5999747

O=C(O)c1ccc(S(=O)(=O)NCc2nc(-c3ccc(NCCc4ccc(C5CCCCC5)cc4)cc3)cs2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.41
OPRK1 P41145 1/20 0.41
ADRB3 P13945 9/20 0.41
KMT2A Q03164 3/20 0.40
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 2/20 0.40
POLB P06746 2/20 0.40
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
PPARG P37231 1/20 0.37
MRE11 P49959 1/20 0.37
ADRB2 P07550 1/20 0.37
ADRB1 P08588 1/20 0.37
MCL1 Q07820 1/20 0.36
BCL2A1 Q16548 1/20 0.36
RORC P51449 1/20 0.36
PHGDH O43175 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5999085 0.94 ADRB3 (0.41) OPRM1OPRK1ADRB3KMT2AALDH1A1
SCHEMBL6001067 0.89 RAB9A (0.42) KMT2AALDH1A1MEN1POLBLMNA
SCHEMBL5999078 0.86 AVPR1B (0.42) ADRB3KMT2AMEN1POLBNPC1
SCHEMBL5999739 0.85 MRE11 (0.40) ADRB3KMT2AALDH1A1MEN1POLB
SCHEMBL6000629 0.85 ADRB3 (0.40) ADRB3KMT2AALDH1A1MEN1POLB
SCHEMBL6000702 0.85 AKR1C3 (0.47) ADRB3KMT2AALDH1A1MEN1POLB
SCHEMBL5999737 0.84 RAB9A (0.40) KMT2AALDH1A1MEN1POLBLMNA
SCHEMBL5999743 0.84 OPRM1 (0.46) OPRM1OPRK1KMT2AALDH1A1MEN1
SCHEMBL5999893 0.82 RAB9A (0.39) KMT2AALDH1A1MEN1POLBLMNA
SCHEMBL6001062 0.82 RAB9A (0.39) KMT2AALDH1A1MEN1POLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 OPRM1 1031/4885OPRK1 2086/4885ADRB3 483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.